Ken Fujioka

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

F. Xavier Pi‐Sunyer, Arne Astrup, Ken Fujioka et al. · New England Journal of Medicine · 2015 · 2.4K citations · Full text

Recombinant Leptin for Weight Loss in Obese and Lean Adults

Steven B. Heymsfield, Andrew S. Greenberg, Ken Fujioka et al. · JAMA · 1999 · 1.4K citations

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Frank L. Greenway, Ken Fujioka, Raymond A Plodkowski et al. · The Lancet · 2010 · 991 citations

Obesity, Metabolic Syndrome, Non-pharmacological Intervention +9

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux, Arne Astrup, Ken Fujioka et al. · The Lancet · 2017 · 813 citations

Obesity, Metabolic Syndrome, Nutrition +8

Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

Priscilla Hollander, Alok Gupta, Raymond A Plodkowski et al. · Diabetes Care · 2013 · 481 citations · Full text